Neoplasms Metastasis Terminated Phase 3 Trials for Ibandronate (DB00710)

Also known as: Neoplasm Metastasis / Metastasis, Neoplasm

IndicationStatusPhase
DBCOND0066909 (Neoplasms Metastasis)Terminated3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00099203A Study to Assess the Efficacy of Intravenous Bondronat (Ibandronate) in Patients With Malignant and Painful Bone DiseaseTreatment
NCT00099177A Study to Assess the Efficacy of Intravenous/Oral Bondronat (Ibandronate) in Patients With Metastatic Bone Disease Experiencing Moderate to Severe PainTreatment